Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
Article in Scientific Reports (October 2022)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in Scientific Reports (October 2022)
Article in Expert Review of Ophthalmology (July 2022)
Article in Current Research in Pharmacology and Drug Discovery (May 2022)